Safety alert for DermaGenius 3.0 reagent
Summary
The French National Agency for Medicines and Health Products Safety (ANSM) has issued a safety alert regarding the DermaGenius 3.0 Complete Multiplex real-time PCR reagent. This alert, registered under number R2607183, informs medical biology analysis laboratories of a security action implemented by PathoNostics.
What changed
The ANSM has issued a safety alert (Information n° R2607183) concerning the DermaGenius 3.0 Complete Multiplex real-time PCR reagent, following a security action initiated by the manufacturer, PathoNostics. The alert is directed at medical biology analysis laboratories, and users have been notified via a letter from the company. The ANSM is not the direct issuer of the security action but is registering it and providing information to affected parties.
Laboratories using this reagent should review the security action details provided by PathoNostics, as outlined in the letter dated March 13, 2026. For specific questions or to understand the implications of this security action, laboratories should contact PathoNostics directly. The ANSM's role here is informational, ensuring awareness within the regulated community.
What to do next
- Review the security action letter from PathoNostics dated 2026-03-13.
- Contact PathoNostics directly for any questions regarding the security action.
Source document (simplified)
Information n° R2607183 destinée aux laboratoires d'analyses de biologie médicale L'ANSM a été informée de la mise en œuvre d’une action de sécurité effectuée par la société PathoNostics.
Les utilisateurs concernés ont reçu le courrier ci-joint.
Cette action de sécurité est enregistrée à l’ANSM sous le n° R2607183.
Pour toute question, merci de vous adresser directement à l’émetteur de l’action de sécurité. Consultez le courrier de la société PathoNostics (13/03/2026)
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ANSM Drug & Device Safety Alerts publishes new changes.